Heart & Lung: The Journal of Acute and Critical Care
Volume 32, Issue 1 , Pages 3-9 , January 2003

Can treatment with angiotensin-converting enzyme inhibitors in elderly patients with moderate to severe chronic heart failure be improved by a nurse-monitored structured care program? A randomized controlled trial

References 

  1. The CONSENSUS Trial Study Group . Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enlalapril Survival Study (CONSENSUS) N Engl J Med. 1987;316:1429–1435
  2. The SOLVD Investigators . Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–691
  3. Ritchie JL, Cheitlin MD, Eagle KA, et al.  Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on evaluation and management of heart failure) Circulation. 1995;92:2764–2784
  4. Task force of the Working Group on Heart failure of the European Society of Cardiology . Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:1527–1560
  5. Swedberg K, Sharpe N. The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction, heart failure or after myocardial infarction. Eur Heart J. 1996;17:1306–1311
  6. Bourassa MG, Gurne O, Bangdiwala SI, et al. , for the Studies of Left Ventricular Dysfunction SOLVD Investigators   Natural history and patterns of current practice in heart failure. J Am Coll Cardiol. 1993;22(Suppl A):14A–19A
  7. Philbin EF, Andreou C, Rocco TA, Lynch LJ, Baker SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol. 1996;77:832–838
  8. Clinical Quality Improvement Network investigators . Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy. Arch Intern Med. 1996;156:1669–1673
  9. Philbin EF. Factors determining angiotensin-converting enzyme inhibitor undertutilization in heart failure in a community setting. Clin Cardiol. 1998;21:103–108
  10. Clarke KE, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J. 1994;71:584–587
  11. Eriksson H. Heart failure: a major public health problem. In:  Andrén L,  Beerman B,  Benson L, et al. editor. Pharmacological treatment of heart failure. Uppsala: Swedish Medical Products Agency; 1993;p. 7–19
  12. Ekman I, Andersson B, Ehnfors M, Matejka G, Persson B, Fagerberg B. Feasibility of a nurse-monitored, outpatient care-program for elderly patients with moderate-to-severe, chronic heart failure. Eur Heart J. 1998;19:1254–1260
  13. Carlson KJ, Lee DC, Goroll AH, Lehay M, Johnson RA. An analysis of physicians' reasons fo prescribing long-term digitalis therapy in outpatients. J Chronic Dis. 1985;38:733–739
  14. Ljungman S, Kjekshus J, Swedberg K. Renal function in severe congestive heart failure during treatment with enalapril. Results of the Cooperative North Scandinavian Enlalapril Survival Study (CONSENSUS). Am J Cardiol. 1992;70:479–487
  15. Packer M, Poole-Wilson PA, Armstrong PW, et al.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999;100:2312–2318
  16. Nanas JN, Alexopoulos G, Anastasia-Nana MI, et al.  Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. J Am Coll Cardiol. 2000;36:2090–2095
  17. Luzier AB, Forrest A, Adelman M, et al.  Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure. Am J Cardiol. 1998;82:465–469
  18. van Veldhuisen DJ, Genth-Zotz S, Brouwer J, et al.  High-versus low-dose ace inhibition in chronic heart failure. J Am Coll Cardiol. 1998;32:1811–1818
  19. Brunner-La Rocca HP, Vaddadi G, Esler MD. Recent insight into therapy of congestive heart failure: focus on ACE inhibitation and angiotensin-II antagonism. J Am Coll Cardiol. 1999;33:1163–1173
  20. O'Keefe S, Lye MDW. Heart failure in the elderly: the same syndrome as the clinical trials?. In:  McMurray JJV,  Cleland JGF editor. Heart failure in clinical practice. London: Martin Dunez; 1996;p. 47–71
  21. Philbin EF, Rocco TA. Use of angiogensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. Am Heart J. 1997;134:188–195

☆ Supported by grants from the Swedish Medical Research Council, Hjärt-och lungsjukas riksförbund, and Merck, Sharp & Dohme.

☆☆ Reprint requests: Inger Ekman, The Sahlgrenska Academy at Göteborg University, Faculty of Health and Caring Sciences, Institute of Nursing, Box 457 405 30, Göteborg, Sweden.

★ 0147-9563/2003/$30.00 + 0

PII: S0147-9563(02)70205-7

doi: 10.1067/mhl.2003.5

Heart & Lung: The Journal of Acute and Critical Care
Volume 32, Issue 1 , Pages 3-9 , January 2003

Article Tools

* Image Usage & Resolution